We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IVDA:NASDAQIveda Solutions, Inc. Analysis

Data as of 2026-04-11 - not real-time

$0.26

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Iveda Solutions trades at $0.2555, hovering just above its computed support of $0.23 and well below the 20‑day SMA of $0.2775, signaling a fragile price footing. Technical gauges are mixed: the RSI sits at 35.4 (Volatility is extreme at 57.5% over 30 days and the stock’s beta of 2.36 points to amplified market swings. Fundamentally, the company is in distress – revenue has collapsed by 64%, margins are deeply negative (operating margin –2.63%, profit margin –60.6%), and cash flow is negative, with a max drawdown of –91.5% and a market cap of only $2.85 M. No dividend is paid, and the balance sheet shows a high debt‑to‑equity ratio of 14.8, underscoring liquidity concerns.
Given the confluence of a low‑priced, highly volatile stock with deteriorating fundamentals and limited liquidity, the outlook remains precarious. While the MACD hints at a short‑term technical bounce, the broader financial health and market sentiment (Fear & Greed Index at “Extreme Greed”) suggest that any upside is speculative and heavily risk‑weighted.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price near support with limited upside
  • Mixed technical signals but overall bearish trend
  • Severe negative earnings and cash flow

Medium Term

1–3 years
Cautious
Model confidence: 8/10

Key Factors

  • Continued revenue decline and widening losses
  • High volatility and beta amplifying market risk
  • Liquidity constraints reflected by low market cap and decreasing volume

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Fundamental restructuring required to reverse negative margins
  • Risk of further capital erosion given high debt‑to‑equity
  • Unclear path to sustainable growth in a competitive security services market

Key Metrics & Analysis

Financial Health

Revenue Growth-64.10%
Profit Margin-60.57%
P/E Ratio0.1
ROE-87.80%
ROA-34.75%
Debt/Equity14.84
P/B Ratio0.3
Op. Cash Flow$-2027501
Free Cash Flow$-919520
Industry P/E30.9

Technical Analysis

TrendBearish
RSI35.4
Support$0.23
Resistance$0.38
MA 20$0.28
MA 50$0.35
MA 200$1.14
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta2.36
Volatility57.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.